Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter V Mental and behavioural disorders,F5_MENTORG,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.31 [0.97-1.77],0.0763577217214439,cis
Chapter V Mental and behavioural disorders,F5_MENTORG,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.09 [0.96-1.24],0.201371992458033,cis
Chapter V Mental and behavioural disorders,F5_MENTORG,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,0.91 [0.75-1.1],0.319453244182747,cis
Chapter V Mental and behavioural disorders,F5_MENTORG,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,1.07 [0.75-1.53],0.691865883264365,cis
Chapter V Mental and behavioural disorders,F5_MENTORG,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,1.2 [0.84-1.71],0.307202891155701,trans
Chapter V Mental and behavioural disorders,F5_MENTORG,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,0.94 [0.79-1.12],0.482728891690497,trans
Chapter V Mental and behavioural disorders,F5_MENTORG,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.12 [0.73-1.74],0.598812455928879,trans
Chapter V Mental and behavioural disorders,F5_MENTORG,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.1 [0.65-1.85],0.728927688401719,trans
Chapter V Mental and behavioural disorders,F5_MENTORG,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.89 [0.19-4.05],0.877137693273121,trans
